INTRODUCTION
Helicobacter pylori (H. pylori) is a helically shaped, micro-aerophilic, and gram-negative bacterium that chronically infects the stomach of 45% of the human population. It causes pathologic effects in the stomach and the duodenum. Its presence increases the risk for peptic ulceration, gastric lymphoma, and adenocarcinoma (gastric cancer) (1) (2) (3) (4) . H. pylori may also contribute to idiopathic thrombocytopenic purpura and iron and vitamin B12 deficiencies in children. Based on epidemiologic information, people living in developing countries are more likely to acquire H. pylori infection (5-7). However, the influence of H. pylori infection on diseases in other organs such as the respiratory system are not fully understood to date. There is some evidence that infection with H. pylori might be associated with the development of bronchiectasis, bronchitis, and lung cancer (7-9), but it seems that H. pylori infection has no direct role in the development and pathophysiology of bronchial asthma (8) (9) (10) . In fact, an inverse relationship between H.
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Allergic asthma is a chronic inflammatory disease of the airways that is characterized by wheezing, coughing, and shortness of breath. Asthma is caused by an exaggerated Th2-mediated immune response to environmental allergens. Allergic asthma is characterized by a Th2 pattern of cytokines and inhibited secretion of IL-12 and IFN-γ (Th1 pattern of cytokines). Type 2 cytokines promote immunoglobulin (Ig) E production and eosinophilic inflammation in the airways (13) (14) (15) .
Microorganisms (such as bacteria and viruses) that are responsible for infection in the respiratory system might play complex roles in the development of asthma as stimulatory or inhibitory agents (16, 17) . Respiratory viral infections (such as influenza virus) could trigger the pathogenesis of aeroallergens. Conversely, some microbialderived particles show adjuvant and anti-atopic activity (6, 17, 18) .
In susceptible patients, triggering a Th1-mediated immune response could suppress Th2 responses while lack of an adequate Th1 response might result in an overactive Th2 response and allergic asthma in the airways (15) .
Microbial products have demonstrated a strong stimulatory effect that is helpful to maintain the balance between Th1 and Th2 responses. The microbes that are effective in controlling and treating asthma could be employed as potential therapeutic tools (6, 15, 18) .
Recent studies have shown a correlation between the presence of H. pylori and a decreased risk of asthma.
However, the results reported by different studies are contradictory (19) (20) (21) . The prevalence of allergic asthma has increased considerably in developed countries. In developed countries, a correlation between allergic asthma and childhood infection with H. pylori is notable (20, 21).
The present review will discuss H. pylori infection and its possible connection with allergic asthma. Moreover, potential therapeutic strategies to use H. pylori as a new tool for the prevention and treatment of allergic asthma will also be reviewed.
Microbes and immune system responses
The immune system reacts against different microbes and produces specific responses for the specialized recognition and elimination of different infectious agents (16, 22) .
Endogenous antigens such as viruses can be eliminated by CD8+ T cells (cytotoxic T lymphocytes) with MHC class I molecules via a cell-mediated cytotoxicity mechanism.
Exogenous microbial antigens such as most bacteria 
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